PHARMABOARDROOM





Education

Switzerland possesses few natural resources; therefore, its most important capital is its well-educated workforce and continuous innovation. Swiss education and research policy is built around this concept, and the country’s educational institutions are world-renowned for their quality.

A federal structure means that the business world, research institutions, and the educational system are in close proximity, while the nation’s ‘dual training system’ means that students can choose between a traditional educational path or engage in vocational training in the service sector, receiving hand-on training on the job.

Made with Visme Infographic Maker

Made with Visme Infographic Maker

Quality of Life


The Region

Why do companies invest in Western Switzerland?


Flawless Operations


Skilled & Flexible Talent


Vibrant Life Sciences Environment


Ease of Setting Up a Business


Proficient Pharma Market


Successful Peer Companies

HubsGoGlobal is a platform under the PharmaBoardroom brand that focuses on the competitive advantages of the Hub and its value proposition in terms of strategic, operational, financial, talent and lifestyle aspects.

PharmaBoardroom provides industry trends, news and reports from all over the world. This site is for senior professionals who want to understand local and global markets.

CONTACT



Greater Geneva Bern area is an initiative of the cantons of
Bern, Fribourg, Vaud, Neuchâtel, Geneva and Valais.

World Trade Center – Av. de Gratta-Paille 2
PO Box 252
1000 Lausanne 22 – Switzerland

CONTACT


Copyright: All rights reserved. No part of this site maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this website, neither PharmaBoardroom nor the authors accept any liabilities for errors and omissions. Opinions expressed in this report are not necessarily those of the authors.

2021 © PharmaBoardroom